Advances in microneedle design for the delivery of drugs, proteins, and cells in the treatment of hypertrophic scars

Abstract

Hypertrophic scars (HS) represent a significant clinical challenge due to their complex pathophysiology and resistance to conventional therapies, often resulting in persistent symptoms such as itching, pain, and impaired joint mobility that compromise patients’ quality of life. Current treatment modalities, including compression therapy, pharmacological agents, radiation, silicone gel, and laser therapies, have faced limitations primarily due to inadequate drug penetration into the dense fibrotic scar tissue. In this context, microneedle-mediated controlled delivery systems have emerged as a promising pharmaceutical platform to enhance localized and sustained delivery of therapeutic agents, including small-molecule drugs, biologic proteins, small interfering RNA, and living cells, directly into HS. This article critically reviews the biological and formulation-related challenges associated with transdermal delivery in scar tissue and highlights recent innovations in microneedle design, material selection, and drug-loading techniques tailored for controlled release applications. Furthermore, it discusses the integration of proteins and cell-based therapies within microneedle platforms and their potential to modulate scar remodeling and inflammation. By addressing current limitations and exploring cutting-edge technologies, this review article aims to guide the development of effective microneedle-mediated strategies for pharmaceutical intervention in hypertrophic scar management.

Keywords

Microneedle / Drug delivery system / Hypertrophic scar / Wound healing

References

[1] Sargazi N, Bodansky D, Shokrollahi K. Pathophysiology of scarring. In: Shokrollahi K, editor. Laser management of scars. Cham: Springer International Publishing; 2020. p. 3-5.

[2] Hong YK, Lin YC, Cheng TL, Lai CH, Chang YH, Huang YL, et al. TEM1/endosialin/CD248 promotes pathologic scarring and TGF-β activity through its receptor stability in dermal fibroblasts. J Biomed Sci 2024; 31: 12. https://doi.org/10.1186/s12929-024-01001-0.

[3] Jeschke MG, Wood FM, Middelkoop E, Bayat A, Teot L, Ogawa R, et al. Scars. Nat Rev Dis Primers 2023; 9: 64. https://doi.org/10.1038/s41572-023-00474-x.

[4] Kim HJ, Kim YH. Comprehensive insights into keloid pathogenesis and advanced therapeutic strategies. Int J Mol Sci 2024; 25: 8776. https://doi.org/10.3390/ijms25168776.

[5] Liu F, Luo Y, Chen H, Xu S, Zhang D, Sang H, et al. Comparison of the efficacy of seven types of microneedles for treating a rabbit hypertrophic scar model. Nanoscale Adv 2023; 5: 927-33. https://doi.org/10.1039/D2NA00604A.

[6] Frech FS, Hernandez L, Urbonas R, Zaken GA, Dreyfuss I, Nouri K. Hypertrophic scars and keloids: advances in treatment and review of established therapies. Am J Clin Dermatol 2023; 24: 225-45. https://doi.org/10.1007/s40257-022-00744-6.

[7] Wu JY, Zou J, Yang QP, Wang HT, Tian HT, Chen LZ, et al. The effects of scar in psychological disorder: a bibliometric analysis from 2003 to 2022. Int Wound J 2024; 21: e14373. https://doi.org/10.1111/iwj.14373.

[8] De Decker I, Beeckman A, Hoeksema H, De Mey K, Verbelen J, De Coninck P, et al. Pressure therapy for scars: myth or reality? A systematic review. Burns 2023; 49: 741-56. https://doi.org/10.1016/j.burns.2023.03.007.

[9] Zhao J, Yang S, Xu Y, Qin S, Bie F, Chen L, et al. Mechanical pressure-induced dedifferentiation of myofibroblasts inhibits scarring via SMYD3/ITGBL1 signaling. Dev Cell 2023; 58: 1139-52.e6. https://doi.org/10.1016/j.devcel.2023.04.014.

[10] DeBruler DM, Baumann ME, Zbinden JC, Blackstone BN, Bailey JK, Supp DM, et al. Improved scar outcomes with increased daily duration of pressure garment therapy. Adv Wound Care (New Rochelle) 2020; 9: 453-61. https://doi.org/10.1089/wound.2020.1161.

[11] Tomtschik J, Anand N, Bustos SS, Martinez-Jorge J, Wyles SP. Practical management of hypertrophic scarring: the mayo clinic experience. Arch Dermatol Res 2024; 316: 77. https://doi.org/10.1007/s00403-023-02802-3.

[12] Khater YBHM, Hussein HA, Abd-el-Raheem TA, El Hanbuli HM, Yassen NN. Assessment of intralesional injection of botulinum toxin type A in hypertrophic scars and keloids: clinical and pathological study. Dermatol Ther 2022; 35: e15748. https://doi.org/10.1111/dth.15748.

[13] Kim S, Woo YR, Cho SH, Lee JD, Kim HS. Clinical efficacy of 5-fluorouracil and bleomycin in dermatology. J Clin Med 2024; 13: 335. https://doi.org/10.3390/jcm13020335.

[14] Choi J, Han YN, Rha EY, Kang HJ, Kim KJ, Park IK, et al. Verapamil-containing silicone gel reduces scar hypertrophy. Int Wound J 2021; 18: 647-56. https://doi.org/10.1111/iwj.13566.

[15] Shen Y, Jin R, Liang X, Deng Z, He J, Ding Y, et al. Angiogenesis modulation-mediated inhibitory effects of tacrolimus on hypertrophic scar formation. Microvasc Res 2023; 145: 104446. https://doi.org/10.1016/j.mvr.2022.104446.

[16] Xiao Z, Zhang F, Cui Z. Treatment of hypertrophic scars with intralesional botulinum toxin type A injections: a preliminary report. Aesth Plast Surg 2009; 33: 409-12. https://doi.org/10.1007/s00266-009-9334-z.

[17] Song H, Tan J, Fu Q, Huang L, Ao M. Comparative efficacy of intralesional triamcinolone acetonide injection during early and static stage of pathological scarring. J Cosmet Dermatol 2019; 18: 874-8. https://doi.org/10.1111/jocd.12690.

[18] Qin Z, Chen F, Chen D, Wang Y, Tan Y, Ban J. Transdermal permeability of triamcinolone acetonide lipid nanoparticles. Int J Nanomedicine 2019; 14: 2485-95. https://doi.org/10.2147/IJN.S195769.

[19] Yuan B, Upton Z, Leavesley D, Fan C, Wang XQ. Vascular and collagen target: a rational approach to hypertrophic scar management. Adv Wound Care 2023; 12: 38-55. https://doi.org/10.1089/wound.2020.1348.

[20] Parrett BM, Donelan MB. Pulsed dye laser in burn scars: current concepts and future directions. Burns. 2010; 36: 443-9. https://doi.org/10.1016/j.burns.2009.08.015.

[21] Kuo YR, Wu WS, Jeng SF, Wang FS, Huang HC, Lin CZ, et al. Suppressed TGF-beta1 expression is correlated with upregulation of matrix metalloproteinase-13 in keloid regression after flashlamp pulsed-dye laser treatment. Lasers Surg Med 2005; 36: 38-42. https://doi.org/10.1002/lsm.20104.

[22] Kuo YR, Wu WS, Jeng SF, Huang HC, Yang KD, Sacks JM, et al. Activation of ERK and p38 kinase mediated keloid fibroblast apoptosis after flashlamp pulsed-dye laser treatment. Lasers Surg Med 2005; 36: 31-7. https://doi.org/10.1002/lsm.20129.

[23] Pan L, Qin H, Li C, Zhang G, Yang L, Zhang L. Efficacy of the neodymium-doped yttrium aluminum garnet laser in the treatment of keloid and hypertrophic scars: a systematic review and meta-analysis. Aesth Plast Surg 2022; 46: 1997-2005. https://doi.org/10.1007/s00266-021-02716-3.

[24] Gauglitz GG, Korting HC, Pavicic T, Ruzicka T, Jeschke MG. Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med 2011; 17: 113-25. https://doi.org/10.2119/molmed.2009.00153.

[25] Trace AP, Enos CW, Mantel A, Harvey VM . Keloids and hypertrophic scars: a spectrum of clinical challenges. Am J Clin Dermatol 2016; 17: 201-23. https://doi.org/10.1007/s40257-016-0175-7.

[26] Jiang SY, Qian SH, Zhou LX, Meng J, Jiang RS, Wang CC, et al. Mapping the 3D remodeling of the extracellular matrix in human hypertrophic scar by multi-parametric multiphoton imaging using endogenous contrast. Heliyon. 2023; 9: e13653. https://doi.org/10.1016/j.heliyon.2023.e13653.

[27] Li YS, Liu AQ, Wang JY, Yang CS, Lv KY, He WF, et al. Suture-anchored cutaneous tension induces persistent hypertrophic scarring in a novel murine model. Burns Trauma 2024; 12: tkae051. https://doi.org/10.1093/burnst/tkae051.

[28] Li JY, Zeng SQ, Zhang EY, Chen L, Jiang JB, Li J. Spatial metabolomics to discover hypertrophic scar relevant metabolic alterations and potential therapeutic strategies: a preliminary study. Bioorg Chem 2024; 153: 107873. https://doi.org/10.1016/j.bioorg.2024.107873.

[29] Ma L, Hua L, Yu WY, Ke L, Li LY. TSG-6 inhibits hypertrophic scar fibroblast proliferation by regulating IRE1α/TRAF2/NF-κB signalling. Int Wound J 2023; 20: 1008-19. https://doi.org/10.1111/iwj.13950.

[30] Yang Z-R, Suo H, Fan J-W, Lv N, Du K, Ma T, et al. Endogenous stimuli-responsive separating microneedles to inhibit hypertrophic scar through remodeling the pathological microenvironment. Nat Commun 2024; 15: 2038. https://doi.org/10.1038/s41467-024-46328-2.

[31] Harn HIC, Ogawa R, Hsu CK, Hughes MW, Tang MJ, Chuong CM. The tension biology of wound healing. Exp Dermatol 2019; 28: 464-71. https://doi.org/10.1111/exd.13460.

[32] Pang JYC, Ma YC, Huang HC, Ma JQ, Zheng YJ, Xiao SC, et al. Mechanical stress-mediated immune and inflammatory regulation: a bibliometric and visualization analysis of mechanoimmunology based on two databases. Front Med 2025; 12: 1698177. https://doi.org/10.3389/fmed.2025.1698177.

[33] Ogawa R. Mechanobiology of scarring. Wound Repair Regen 2011; 19: S2-9. https://doi.org/10.1111/j.1524-475X.2011.00707.x.

[34] Ji XJ, Tang Z, Shuai WW, Zhang ZR, Li JY, Chen L, et al. Endogenous peptide LYENRL prevents the activation of hypertrophic scar-derived fibroblasts by inhibiting the TGF-β1/Smad pathway. Life Sci 2019; 231: 116674. https://doi.org/10.1016/j.lfs.2019.116674.

[35] Kuehlmann B, Bonham CA, Zucal I, Prantl L, Gurtner G. Mechanotransduction in wound healing and fibrosis. J Clin Med 2020; 9: 1423. https://doi.org/10.3390/jcm9051423.

[36] Zhang Q, Shi L, He H, Liu X, Huang Y, Xu D, et al. Down-regulating scar formation by microneedles directly via a mechanical communication pathway. ACS Nano 2022; 16: 10163-78. https://doi.org/10.1021/acsnano.1c11016.

[37] Mascharak S, DesJardins-Park HE, Davitt MF, Griffin M, Borrelli MR, Moore AL, et al. Preventing Engrailed-1 activation in fibroblasts yields wound regeneration without scarring. Science. 2021; 372: 362-+. https://doi.org/10.1126/science.aba2374.

[38] Wei CX, You CA, Zhou LM, Liu HL, Zhou SH, Wang XA, et al. Antimicrobial hydrogel microneedle loading verteporfin promotes skin regeneration by blocking mechanotransduction signaling. Chem Eng J 2023; 472: 144866. https://doi.org/10.1016/j.cej.2023.144866.

[39] Lin Y, Dervisevic M, Yoh HZ, Guo K, Voelcker NH. Tailoring design of microneedles for drug delivery and biosensing. Mol Pharm 2025; 22: 678-707. https://doi.org/10.1021/acs.molpharmaceut.4c01266.

[40] Zhang X, Zhou C, Chen T, Jiang Z, Lu C, Wu C, et al. State-of-the-art strategies to enhance the mechanical properties of microneedles. Int J Pharm 2024; 663: 124547. https://doi.org/10.1016/j.ijpharm.2024.124547.

[41] Lin SQ, Quan GL, Hou AL, Yang PP, Peng TT, Gu YK, et al. Strategy for hypertrophic scar therapy: improved delivery of triamcinolone acetonide using mechanically robust tip-concentrated dissolving microneedle array. J Control Release 2019; 306: 69-82. https://doi.org/10.1016/j.jconrel.2019.05.038.

[42] Younas A, Asad M, Wan X, Zhang Y, Ma X, Wang L, et al. Oregano essential oil-infused mucin microneedle patch for the treatment of hypertrophic scar. Int J Pharm 2024; 665: 124748. https://doi.org/10.1016/j.ijpharm.2024.124748.

[43] Yang B, Dong Y, Shen Y, Hou A, Quan G, Pan X, et al. Bilayer dissolving microneedle array containing 5-fluorouracil and triamcinolone with biphasic release profile for hypertrophic scar therapy. Bioact Mater 2021; 6: 2400-11. https://doi.org/10.1016/j.bioactmat.2021.01.014.

[44] Wang B, Zhang S, Cheng A, Yan J, Gao Y. Soluble polymer microneedles loaded with interferon alpha 1b for treatment of hyperplastic scar. Polymers (Basel) 2023; 15: 15. https://doi.org/10.3390/polym15122621.

[45] Huang Y, Peng TT, Hu WS, Gao XY, Chen YY, Zhang Q, et al. Fully armed photodynamic therapy with spear and shear for topical deep hypertrophic scar treatment. J Control Release 2022; 343: 408-19. https://doi.org/10.1016/j.jconrel.2022.01.043.

[46] Ghelich P, Samandari M, Hassani Najafabadi A, Tanguay A, Quint J, Menon N, et al. Dissolvable immunomodulatory microneedles for treatment of skin wounds. Adv Healthc Mater 2024; 13: e2302836. https://doi.org/10.1002/adhm.202302836.

[47] Chun YY, Tan WWR, Vos MIG, Chan WK, Tey HL, Tan NS, et al. Scar prevention through topical delivery of gelatin-tyramine-siSPARC nanoplex loaded in dissolvable hyaluronic acid microneedle patch across skin barrier. Biomater Sci 2022; 10: 3963-71. https://doi.org/10.1039/D2BM00572G.

[48] Meng S, Wei Q, Chen S, Liu X, Cui S, Huang Q, et al. MiR-141-3p-functionalized exosomes loaded in dissolvable microneedle arrays for hypertrophic scar treatment. Small (Weinheim an der Bergstrasse, Germany) 2023; 20: e2305374. https://doi.org/10.1002/smll.202305374.

[49] Liu M, Zhou X, Wang Y, Zhao W, Zhao X, Li L, et al. A strategy involving microporous microneedles integrated with CAR-TREM2-macrophages for scar management by regulating fibrotic microenvironment. Adv Mater 2024; 36: e2406153. https://doi.org/10.1002/adma.202406153.

[50] Lyu S, Liu Q, Yuen HY, Xie H, Yang Y, Yeung KW, et al. A differential-targeting core-shell microneedle patch with coordinated and prolonged release of mangiferin and MSC-derived exosomes for scarless skin regeneration. Mater Horiz 2024; 11: 2667-84. https://doi.org/10.1039/D3MH01910A.

[51] Li C, Yi B, Xu Q, Ma J, Yuan L, Liu Y, et al. ADSCC-CM-induced keratin hydrogel-based bioactive microneedle patch containing triamcinolone acetonide for the treatment of pathological scar. Adv Funct Mater 2024; 34: 2400457.

[52] Disphanurat W, Sivapornpan N, Srisantithum B, Leelawattanachai J. Efficacy of a triamcinolone acetonide-loaded dissolving microneedle patch for the treatment of hypertrophic scars and keloids: a randomized, double-blinded, placebo-controlled split-scar study. Arch Dermatol Res 2023; 315: 989-97. https://doi.org/10.1007/s00403-022-02473-6.

[53] Huang Y, Li J, Wang Y, Chen D, Huang J, Dai W, et al. Intradermal delivery of an angiotensin II receptor blocker using a personalized microneedle patch for treatment of hypertrophic scars. Biomater Sci 2023; 11: 583-95. https://doi.org/10.1039/D2BM01631A.

[54] Hao R, Wang C, Yang C, Chang J, Wang X, Yuan B, et al. Transdermal delivery of protocatechuic aldehyde using hyaluronic acid/gelatin-based microneedles for the prevention and treatment of hypertrophic scars. Eur J Pharm Biopharm 2023; 184: 202-13. https://doi.org/10.1016/j.ejpb.2023.02.003.

[55] Ning X, Wiraja C, Chew WTS, Fan C, Xu C. Transdermal delivery of Chinese herbal medicine extract using dissolvable microneedles for hypertrophic scar treatment. Acta Pharm Sin B 2021; 11: 2937-44. https://doi.org/10.1016/j.apsb.2021.03.016.

[56] Zhao B, Guo W, Zhou X, Xue Y, Wang T, Li Q, et al. Ferroptosis-mediated synergistic therapy of hypertrophic scarring based on metal-organic framework microneedle patch. Adv Funct Mater 2023; 33: 2300575. https://doi.org/10.1002/adfm.202300575.

[57] Wu T, Hou X, Li J, Ruan H, Pei L, Guo T, et al. Microneedle-mediated biomimetic cyclodextrin metal organic frameworks for active targeting and treatment of hypertrophic scars. ACS Nano 2021; 15: 20087-104. https://doi.org/10.1021/acsnano.1c07829.

[58] Ning X, Chen S, Yang Y, Hwang J, Wiraja C, Zhang C, et al. Photodynamic bubble-generating microneedles for enhanced transdermal cancer therapy. ACS Appl Polym Mater 2021; 3: 6502-12. https://doi.org/10.1021/acsapm.1c01219.

[59] Chen D, Zhang Y, Long W, Chai L, Myint TP, Zhou W, et al. Visible light-driven photodynamic therapy for hypertrophic scars with MOF armored microneedles patch. Front Chem 2023; 11: 1128255. https://doi.org/10.3389/fchem.2023.1128255.

[60] Zhang Y, Wang S, Yang Y, Zhao S, You J, Wang J, et al. Scarless wound healing programmed by core-shell microneedles. Nat Commun 2023; 14: 3431. https://doi.org/10.1038/s41467-023-39129-6.

[61] Lim DZJ, Chun YY, Tan F, Monteiro AY, Cheng HM, Lee JY, et al. Small interfering RNA microneedle patches versus silicone sheets in reducing postoperative scars: a randomized single-blinded intraindividually controlled clinical trial. Br J Dermatol 2024; 192: 19-26. https://doi.org/10.1093/bjd/ljae347.

[62] Wang M, Han Y, Yu X, Liang L, Chang H, Yeo DC, et al. Upconversion nanoparticle powered microneedle patches for transdermal delivery of siRNA. Adv Healthc Mater 2020; 9: e1900635. https://doi.org/10.1002/adhm.201900635.

[63] Lee K, Xue Y, Lee J, Kim HJ, Liu Y, Tebon P, et al. A patch of detachable hybrid microneedle depot for localized delivery of mesenchymal stem cells in regeneration therapy. Adv Funct Mater 2020; 30: 552876. https://doi.org/10.1002/adfm.202000086.

[64] Jiang S, Zhou J, Wang L, Liu X, Sun J, Zhuang Y, et al. Remolding microenvironmental homeostasis for enhancing regenerative hypertrophic scar treatment based on functionalized microneedles. Interdiscip Mater 2025; 4: 728-44. https://doi.org/10.1002/idm2.70000.

[65] Vettorato E, Volonté P, Musazzi UM, Cilurzo F, Casiraghi A. Skin microincision technique to enhance drug penetration for the treatment of keloid and hypertrophic scars. Int J Pharm 2025; 671: 125259. https://doi.org/10.1016/j.ijpharm.2025.125259.

[66] Yang J, Liu X, Fu Y, Song Y. Recent advances of microneedles for biomedical applications: drug delivery and beyond. Acta Pharm Sin B 2019; 9: 469-83. https://doi.org/10.1016/j.apsb.2019.03.007.

[67] Xu Y, Bian Q, Zhang Y, Zhang Y, Li D, Ma X, et al. Single-dose of integrated bilayer microneedles for enhanced hypertrophic scar therapy with rapid anti-inflammatory and sustained inhibition of myofibroblasts. Biomaterials. 2024; 312: 122742. https://doi.org/10.1016/j.biomaterials.2024.122742.

[68] Hao Y, Chen Y, He X, Yang F, Han R, Yang C, et al. Near-infrared responsive 5-fluorouracil and indocyanine green loaded MPEG-PCL nanoparticle integrated with dissolvable microneedle for skin cancer therapy. Bioact Mater 2020; 5: 542-52. https://doi.org/10.1016/j.bioactmat.2020.04.002.

[69] Lopez-Ramirez MA, Soto F, Wang C, Rueda R, Shukla S, Silva-Lopez C, et al. Built-in active microneedle patch with enhanced autonomous drug delivery. Adv Mater 2020; 32: e1905740. https://doi.org/10.1002/adma.201905740.

[70] DeMuth PC, Su X, Samuel RE, Hammond PT, Irvine DJ. Nano-layered microneedles for transcutaneous delivery of polymer nanoparticles and plasmid DNA. Adv Mater 2010; 22: 4851-6. https://doi.org/10.1002/adma.201001525.

[71] Yang GH, Yang JQ, Diao ZP, Long JJ, Shu ZW, Liu CK, et al. Cascade-targeting pH/ROS microneedles promote scarless diabetic wound healing by macrophage metaboimmune reprogramming. Sci Adv 2025; 11: eadw3834. https://doi.org/10.1126/sciadv.adw3834.

[72] Yan X, Jiang RH, Tang QH, Tan Q, Cooper M, Wang YW. Targeting local glucocorticoid metabolism with a silk fibroin microneedle for more effective hypertrophic scar repair. Int J Biol Macromol 2025; 319: 145753. https://doi.org/10.1016/j.ijbiomac.2025.145753.

[73] Zhang XL, Wang ZL, Jiang H, Zeng HJ, An N, Liu B, et al. Self-powered enzyme-linked microneedle patch for scar-prevention healing of diabetic wounds. Sci Adv 2023; 9: eadh1415. https://doi.org/10.1126/sciadv.adh1415.

[74] He J, Zhang Y, Yu X, Xu C. Wearable patches for transdermal drug delivery. Acta Pharm Sin B 2023; 13: 2298-309. https://doi.org/10.1016/j.apsb.2023.05.009.

[75] Liu T, Chen M, Fu J, Sun Y, Lu C, Quan G, et al. Recent advances in microneedles-mediated transdermal delivery of protein and peptide drugs. Acta Pharm Sin B 2021; 11: 2326-43. https://doi.org/10.1016/j.apsb.2021.03.003.

[76] Zhang S, Qiu Y, Gao Y. Enhanced delivery of hydrophilic peptides in vitro by transdermal microneedle pretreatment. Acta Pharm Sin B 2014; 4: 100- 4. https://doi.org/10.1016/j.apsb.2013.12.011.

[77] Zhuang ZM, Wang Y, Feng ZX, Lin XY, Wang ZC, Zhong XC, et al. Targeting diverse wounds and scars: recent innovative bio-design of microneedle patch for comprehensive management. Small (Weinheim an der Bergstrasse, Germany) 2024; 20: e2306565. https://doi.org/10.1002/smll.202306565.

[78] Barrat FJ, Crow MK, Ivashkiv LB. Interferon target-gene expression and epigenomic signatures in health and disease. Nat Immunol 2019; 20: 1574-83. https://doi.org/10.1038/s41590-019-0466-2.

[79] Ye L, Schnepf D, Staeheli P. Interferon-λ orchestrates innate and adaptive mucosal immune responses. Nat Rev Immunol 2019; 19: 614-25. https://doi.org/10.1038/s41577-019-0182-z.

[80] Hu WS, Peng TT, Huang Y, Ren T, Chen HY, Chen YY, et al. Hyaluronidase-powered microneedles for significantly enhanced transdermal delivery efficiency. J Control Release 2023; 353: 380-90. https://doi.org/10.1016/j.jconrel.2022.11.046.

[81] Locke KW, Maneval DC, LaBarre MJ. ENHANZE® drug delivery technology: a novel approach to subcutaneous administration using recombinant human hyaluronidase PH20. Drug Deliv 2019; 26: 98-106. https://doi.org/10.1080/10717544.2018.1551442.

[82] Zhang Z, Chen YS, Xu H, Wo Y, Zhang Z, Liu Y, et al. 5-Aminolevulinic acid loaded ethosomal vesicles with high entrapment efficiency for in vitro topical transdermal delivery and photodynamic therapy of hypertrophic scars. Nanoscale 2016; 8: 19270-9. https://doi.org/10.1039/C6NR06872C.

[83] Kang S, Kim J, Ahn M, Kim J, Heo MG, Min DH, et al. RNAi nanotherapy for fibrosis: highly durable knockdown of CTGF/CCN-2 using siRNA-DegradaBALL (LEM-S401) to treat skin fibrotic diseases. Nanoscale 2020; 12: 6385-93. https://doi.org/10.1039/C9NR10305H.

[84] Kim B, Park JH, Sailor MJ. Rekindling RNAi therapy: materials design requirements for in vivo siRNA delivery. Adv Mater 2019; 31: e1903637. https://doi.org/10.1002/adma.201903637.

[85] Andrianov AK, DeCollibus DP, Gillis HA, Kha HH, Marin A, Prausnitz MR, et al. Poly di(carboxylatophenoxy)phosphazene is a potent adjuvant for intradermal immunization. Proc Natl Acad Sci USA 2009; 106: 18936-41. https://doi.org/10.1073/pnas.0908842106.

[86] Maalej KM, Merhi M, Inchakalody VP, Mestiri S, Alam M, Maccalli C, et al. CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances. Mol Cancer 2023; 22: 20. https://doi.org/10.1186/s12943-023-01723-z.

[87] Long L, Ji D, Hu C, Yang L, Tang S, Wang Y. Microneedles for in situ tissue regeneration. Mater Today Bio 2023; 19: 100579. https://doi.org/10.1016/j.mtbio.2023.100579.

[88] Ala M. The beneficial effects of mesenchymal stem cells and their exosomes on myocardial infarction and critical considerations for enhancing their efficacy. Ageing Res Rev 2023; 89: 101980. https://doi.org/10.1016/j.arr.2023.101980.

[89] Noh CH, Park S, Seong HR, Lee AY, Tsolmon KE, Geum D, et al. An exosome-rich conditioned medium from human amniotic membrane stem cells facilitates wound healing via increased reepithelization, collagen synthesis, and angiogenesis. Cells 2023; 12: 2698. https://doi.org/10.3390/cells12232698.

[90] Wang W, Liu P, Zhu W, Li T, Wang Y, Wang Y, et al. Skin organoid transplantation promotes tissue repair with scarless in frostbite. Protein Cell. 2024; 16: 239-58. https://doi.org/10.1093/procel/pwae055.

[91] Jackson WM, Nesti LJ, Tuan RS. Mesenchymal stem cell therapy for attenuation of scar formation during wound healing. Stem Cell Res Ther 2012; 3: 20. https://doi.org/10.1186/scrt111.

[92] Hu P, Yang QX, Wang Q, Shi CS, Wang DL, Armato U, et al. Mesenchymal stromal cells-exosomes: a promising cell-free therapeutic tool for wound healing and cutaneous regeneration. Burns Trauma 2019; 7: 38. https://doi.org/10.1186/s41038-019-0178-8.

[93] Chen HB, Hou K, Wu YP, Liu ZM. Use of adipose stem cells against hypertrophic scarring or keloid. Front Cell Dev Biol 2022; 9: 823694. https://doi.org/10.3389/fcell.2021.823694.

[94] Kou M, Huang L, Yang J, Chiang Z, Chen S, Liu J, et al. Mesenchymal stem cell-derived extracellular vesicles for immunomodulation and regeneration: a next generation therapeutic tool?Cell Death Dis 2022; 13: 580. https://doi.org/10.1038/s41419-022-05034-x.

[95] Guillamat-Prats R. The role of MSC in wound healing, scarring and regeneration. Cells 2021; 10: 1729. https://doi.org/10.3390/cells10071729.

[96] Li SY, Yang JX, Sun JC, Chen ML. Adipose-derived mesenchymal stem cells alleviate hypertrophic scar by inhibiting bioactivity and inducing apoptosis in hypertrophic scar fibroblasts. Cells 2022; 11: 4024. https://doi.org/10.3390/cells11244024.

[97] Seo BF, Jung SN. The immunomodulatory effects of mesenchymal stem cells in prevention or treatment of excessive scars. Stem Cells Int 2016; 2016: 6937976. https://doi.org/10.1155/2016/6937976.

[98] Zhang CY, Wang T, Zhang L, Chen PH, Tang SJ, Chen AZ, et al. Combination of lyophilized adipose-derived stem cell concentrated conditioned medium and polysaccharide hydrogel in the inhibition of hypertrophic scarring. Stem Cell Res Ther 2021; 12: 23. https://doi.org/10.1186/s13287-020-02061-3.

[99] An Y, Lin SY, Tan XJ, Zhu SO, Nie FF, Zhen YH, et al. Exosomes from adipose-derived stem cells and application to skin wound healing. Cell Prolif 2021; 54: e12993. https://doi.org/10.1111/cpr.12993.

[100] Ji S, Li Y, Xiang L, Liu M, Xiong M, Cui W, et al. Cocktail cell-reprogrammed hydrogel microspheres achieving scarless hair follicle regeneration. Adv Sci 2024; 11: e2306305. https://doi.org/10.1002/advs.202306305.

[101] Wu X, Huang D, Xu Y, Chen G, Zhao Y. Microfluidic templated stem cell spheroid microneedles for diabetic wound treatment. Adv Mater 2023; 35: e2301064. https://doi.org/10.1002/adma.202301064.

[102] Wang Y, Song P, Wu L, Su Z, Gui X, Gao C, et al. In situ photo-crosslinked adhesive hydrogel loaded with mesenchymal stem cell-derived extracellular vesicles promotes diabetic wound healing. J Mater Chem B 2023; 11: 837-51. https://doi.org/10.1039/D2TB02371G.

[103] Abedanzadeh M, Abolmaali SS, Heidari R, Aalaei E, Kaviani M, Dara M, et al. Photo-crosslinked hyaluronic acid hydrogels designed for simultaneous delivery of mesenchymal stem cells and tannic acid: advancing towards scarless wound healing. Int J Biol Macromol 2024; 281: 136394. https://doi.org/10.1016/j.ijbiomac.2024.136394.

[104] Xu Y, Wu X, Zhang X, Zu Y, Tan Q, Zhao Y. Living microneedle patch with adipose-derived stem cells embedding for diabetic ulcer healing. Adv Funct Mater 2023; 33: 2209986. https://doi.org/10.1002/adfm.202209986.

[105] Wu X, Zhu H, Che J, Xu Y, Tan Q, Zhao Y. Stem cell niche-inspired microcarriers with ADSCs encapsulation for diabetic wound treatment. Bioact Mater 2023; 26: 159-68. https://doi.org/10.1016/j.bioactmat.2023.02.031.

[106] Fan L, Zhang X, Wang L, Song Y, Yi K, Wang X, et al. Bioinspired porous microneedles dwelled stem cells for diabetic wound treatment. Adv Funct Mater 2024; 34: 2316742. https://doi.org/10.1002/adfm.202316742.

[107] Kim EM, Lee GM, Lee S, Kim S-J, Lee D, Yoon DS, et al. Effects of mechanical properties of gelatin methacryloyl hydrogels on encapsulated stem cell spheroids for 3D tissue engineering. Int J Biol Macromol 2022; 194: 903-13. https://doi.org/10.1016/j.ijbiomac.2021.11.145.

[108] Kim S-J, Byun H, Lee S, Kim E, Lee GM, Huh SJ, et al. Spatially arranged encapsulation of stem cell spheroids within hydrogels for the regulation of spheroid fusion and cell migration. Acta Biomater 2022; 142: 60-72. https://doi.org/10.1016/j.actbio.2022.01.047.

[109] Ryu N-E, Lee S-H, Park H. Spheroid culture system methods and applications for mesenchymal stem cells. Cells. 2019; 8: 1620. https://doi.org/10.3390/cells8121620.

[110] Chen H, Fang Y, Luo Z, Wang Y, Sun W, Zhao Y. Emerging microfluidics for bioreactor. Mater Today 2025; 86: 356-92. https://doi.org/10.1016/j.mattod.2025.03.009.

[111] Huang J, Chen H, Li N, Shang L, Bi Y, Zhao Y. Harvesting stem cell exosomes from herringbone microfluidic bioreactor for wound healing. Nano Today 2023; 52: 101983. https://doi.org/10.1016/j.nantod.2023.101983.

[112] Huang J, Chen H, Luo Z, Nie M, Wang J, Lu L, et al. Genetically engineered stromal cell exosomes from high-throughput herringbone microfluidics. ACS Nano 2025; 19: 10568-77. https://doi.org/10.1021/acsnano.5c01773.

[113] Dutta SD, An JM, Hexiu J, Randhawa A, Ganguly K, Patil TV, et al. 3D bioprinting of engineered exosomes secreted from M2-polarized macrophages through immunomodulatory biomaterial promotes in vivo wound healing and angiogenesis. Bioact Mater 2025; 45: 345-62. https://doi.org/10.1016/j.bioactmat.2024.11.026.

[114] Mbituyimana B, Adhikari M, Qi FY, Shi ZJ, Fu LN, Yang G. Microneedle-based cell delivery and cell sampling for biomedical applications. J Control Release 2023; 362: 692-714. https://doi.org/10.1016/j.jconrel.2023.09.013.

[115] Bauleth-Ramos T, El-Sayed N, Fontana F, Lobita M, Shahbazi M-A, Santos HA. Recent approaches for enhancing the performance of dissolving microneedles in drug delivery applications. Mater Today 2023; 63: 239-87. https://doi.org/10.1016/j.mattod.2022.12.007.

[116] Fang A, Wang Y, Guan N, Zuo Y, Lin L, Guo B, et al. Porous microneedle patch with sustained delivery of extracellular vesicles mitigates severe spinal cord injury. Nat Commun 2023; 14: 4011. https://doi.org/10.1038/s41467-023-39745-2.

[117] Gualeni B, Coulman SA, Shah D, Eng PF, Ashraf H, Vescovo P, et al. Minimally invasive and targeted therapeutic cell delivery to the skin using microneedle devices. Br J Dermatol 2018; 178: 731-9. https://doi.org/10.1111/bjd.15923.

[118] Li HJ, Wang ZJ, Archibong E, Wu Q, Chen GJ, Hu QY, et al. Scattered seeding of CAR T cells in solid tumors augments anticancer efficacy. Natl Sci Rev 2022; 9: nwab172. https://doi.org/10.1093/nsr/nwab172.

[119] Chang H, Chew SWT, Zheng MJ, Lio DCS, Wiraja C, Mei Y, et al. Cryomicroneedles for transdermal cell delivery. Nat Biomed Eng 2021; 5: 1008-18. https://doi.org/10.1038/s41551-021-00720-1.

[120] Olowe M, Parupelli SK, Desai S. A review of 3D-printing of microneedles. Pharmaceutics 2022; 14: 2693. https://doi.org/10.3390/pharmaceutics14122693.